| JYSB2101129 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2021-09-13 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2400094 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2024-04-25 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2101145 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2021-10-11 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2000285 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2020-06-19 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-06-23 | view |
| JXSS2100015 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-02-19 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag International NV | Certificate Issued | 2021-11-12 | view |
| JYSZ2300047 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | License Renew | 2023-10-31 | | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag AG | | | view |
| CXSL2200528 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2022-10-20 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JYSB2000066 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2020-02-29 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-03-05 | view |
| JYSB2500003 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2025-01-03 | | Cilag AG;Janssen-Cilag AG | | | view |
| CXSL2300110 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2023-02-09 | | Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd | | | view |
| JYSB2000518 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2020-10-16 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-11-23 | view |
| JYSB2300079 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| CXSL2400135 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2024-02-21 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JYSB2200005 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2022-01-07 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2000086 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2020-03-18 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-03-26 | view |
| JXSS2100016 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-02-19 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag International NV | Certificate Issued | 2021-11-12 | view |
| JYSZ2300046 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | License Renew | 2023-10-31 | | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2500002 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2025-01-03 | | Cilag AG;Janssen-Cilag AG | | | view |
| CXSL2200529 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2022-10-20 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JXSS2000019 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Import Drug Application | 2020-07-03 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2020-07-02 | view |
